Chinenye Iwuji, Head of Medical Oncology at Lakeshore Cancer Center, shared on LinkedIn:
“I thoroughly enjoyed participating in this morning’s panels discussing the latest data in colorectal and hepatobiliary cancers.
We discussed the practicality of adopting these recommendations in our environment and the necessity to collect our own data.
The African population is consistently under-represented (on average less than 5%) in clinical trials. It is time to address this disparity.”
Other articles about hepatobiliary cancers on OncoDaily.